Aethlon Medical Inc

Company Profile

Aethlon Medical Inc had its IPO on 2001-01-02 under the ticker symbol AEMD.

The company operates in the Healthcare sector and Medical Devices industry. Aethlon Medical Inc has a staff strength of 14 employees.

Stock update

Shares of Aethlon Medical Inc opened at $0.42 at the start of the last trading session i.e. 2023-03-19.

The stocks traded within a range of $0.38 - $0.42, and closed at $0.39.

This is a -4.88% slip from the previous day's closing price.

A total volume of 203,600 shares were traded at the close of the day’s session.

In the last one week, shares of Aethlon Medical Inc have slipped by -11.36%.

Aethlon Medical Inc's Key Ratios

Aethlon Medical Inc has a market cap of $11.24 million, indicating a price to book ratio of 0.4273 and a price to sales ratio of 228.4526.

In the last 12-months Aethlon Medical Inc’s revenue was $13116 with a gross profit of $294165 and an EBITDA of $-13019756. The EBITDA ratio measures Aethlon Medical Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Aethlon Medical Inc’s operating margin was -100689.45% while its return on assets stood at -38.71% with a return of equity of -70.56%.

In Q4, Aethlon Medical Inc’s quarterly earnings growth was a positive 0% while revenue growth was a negative 61.7%.

Aethlon Medical Inc’s PE and PEG Ratio

Forward PE

0.2102

Trailing PE

0

PEG

0

Its diluted EPS in the last 12-months stands at $-0.72 per share while it has a forward price to earnings multiple of 0.2102 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Aethlon Medical Inc’s profitability.

Aethlon Medical Inc stock is trading at a EV to sales ratio of 1.0661 and a EV to EBITDA ratio of 0.7672. Its price to sales ratio in the trailing 12-months stood at 228.4526.

Aethlon Medical Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$20.72 million

Total Liabilities

$2.44 million

Operating Cash Flow

$0

Capital Expenditure

$931039.67

Dividend Payout Ratio

0%

Aethlon Medical Inc ended 2023 with $20.72 million in total assets and $0 in total liabilities. Its intangible assets were valued at $20.72 million while shareholder equity stood at $17.28 million.

Aethlon Medical Inc ended 2023 with $0 in deferred long-term liabilities, $2.44 million in other current liabilities, 22971.00 in common stock, $-139892032.00 in retained earnings and $0 in goodwill. Its cash balance stood at $17.50 million and cash and short-term investments were $17.50 million. The company’s total short-term debt was $264,278 while long-term debt stood at $0.

Aethlon Medical Inc’s total current assets stands at $18.17 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $0.00 compared to accounts payable of $226791.00 and inventory worth $0.

In 2023, Aethlon Medical Inc's operating cash flow was $0 while its capital expenditure stood at $931039.67.

Comparatively, Aethlon Medical Inc paid $0 in dividends in 2023.

Other key metrics

Current Trading Price

$0.39

52-Week High

$2.46

52-Week Low

$0.23

Analyst Target Price

$7.38

Aethlon Medical Inc stock is currently trading at $0.39 per share. It touched a 52-week high of $2.46 and a 52-week low of $2.46. Analysts tracking the stock have a 12-month average target price of $7.38.

Its 50-day moving average was $0.5 and 200-day moving average was $0.73 The short ratio stood at 0.09 indicating a short percent outstanding of 0%.

Around 106.5% of the company’s stock are held by insiders while 581% are held by institutions.